PhaseBio Pharmaceuticals Inc: 8-K filed Jul 12, 2024

Form type

8-K

Filing date

Jul 12, 2024

Accession number

0001193125-24-178615

Filer

PhaseBio Pharmaceuticals Inc (CIK 1169245)